Randomized pilot study of camrelizumab with or without autologous cytokine-induced killer cells in refractory clear cell renal cell carcinoma
by Johnson, Jeffrey S., Miller, Justin W., Hatoum, Firas, Schell, Michael J., Yu, Xiaoqing, Roman Souza, Gabriel, Mizelle, Sarah, Gullapalli, Keerthi, Fazili, Adnan, Jain, Rohit, Chatzkel, Jonathan, Cen, Ling, Dhillon, Jasreman, Cubitt, Christopher, Yao, Jiqiang, Whiting, Junmin, Li, Jiannong, Swank, Jennifer, Jameel, Ghazal, Zhang, Jingsong, Wang, Xuefeng, Spiess, Philippe E., Fishman, Mayer & Chahoud, Jad | May 25, 2026 | Articles |
